Affecting up to 50% of patients with heart failure, iron deficiency independently worsens functional status, symptoms, and cardiovascular outcomes, regardless of whether anemia is present. Patient-level meta-analyses consistently show improvements in functional capacity, symptoms, and reductions in heart failure hospitalizations and cardiovascular death with IV iron therapy. This educational activity will equip clinicians, including heart failure specialists and cardiologists, with the knowledge and skills to effectively implement evidence-based IV iron replacement strategies informed by recent clinical trial evidence and updated guidelines in their clinical practice.
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty:
Robert J. Mentz, MD
Chief, Heart Failure Section
Duke University School of Medicine
Durham, NC
Dr. Mentz has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: American Regent, CSL Vifor, Pharmacosmos
Contracted Research: American Regent, CSL Vifor, Pharmacosmos
Piotr Ponikowski, MD, PhD, FESC, FHFA
Medical University, Centre for Heart Disease
University Hospital in Wroclaw
Wroclaw, Poland
Dr. Ponikowski has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: AbbottVascular, American Regent, Amgen, AstraZeneca, Bayer, BoehringerIngelheim, CSL Vifor, Cytokinetics, Impulse Dynamics, Merck, Novartis, Rad-cliffe Group Ltd, Servier.
Reviewers/Content Planners/Authors:- Brian P. McDonough, MD, FAAFP or any other Peer Reviewer used), has no relevant relationships to disclose.
- Tim Person has no relevant relationships to disclose.
- Katie Sheridan, PhD, has no relevant relationships to disclose.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Enhance the diagnosis of patients with iron deficiency and heart failure
- Evaluate current clinical practice guidelines in managing patients with iron deficiency and heart failure
- Interpret the efficacy and safety of IV iron therapy in managing patients with iron deficiency and heart failure
Target Audience
This activity has been designed to meet the educational needs of cardiologists and nephrologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with iron deficiency.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 0.25 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.Global Learning Collaborative (GLC) designates this activity for 0.25 contact hour(s)/0.025 CEUs of pharmacy contact hour(s).
The Universal Activity Number for this program is JA0006235-0000-25-065-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit(s). Approval is valid until June 3, 2026. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Provider(s)/Educational Partner(s)
Our ultimate goal is to improve the care being delivered to patients, and our high-quality, evidence-based CME initiatives reflect our dedication to the creation and execution of excellence and are the product of shared research, knowledge, and clinical practice skills across the healthcare continuum.
Commercial Support
This activity is supported by an independent educational grant from CSL Vifor.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!